Clinical Trials Browser

Phase 2/3 × Immunotherapy, Adoptive × Gastrointestinal × Clear all

NCT02851784 2021-03-04

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular